Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility GroupHKSE:01951 -2.26%81 Days Payable is 49.95 as of Dec. 2025, which is 3% above its 10-year median of 48.33. GuruFocus rates HKSE:01951 with a GF Score™ of 81/100 and a GF Value™ of HK$3.74 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Jinxin Fertility Group ranks worse than 57.99% on this metric.
The historical rank and industry rank for Jinxin Fertility Group's Days Payable or its related term are showing as below:
HKSE:01951'
s Days Payable Range Over the Past 10 Years
Min: 40.76 Med: 48.33 Max: 71.58
Current: 47.88
During the past 10 years, Jinxin Fertility Group's highest Days Payable was 71.58. The lowest was 40.76. And the median was 48.33.
HKSE:01951's Days Payable is ranked worse than 57.99% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 56.95
vs HKSE:01951: 47.88
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01951 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Jinxin Fertility Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group (HKSE:01951) has a Days Payable of 49.95 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jinxin Fertility Group and its competitors. This is near median its historical median of 48.33. Over the past decade, Jinxin Fertility Group's Days Payable has ranged from 40.76 to 71.58. According to the industry distribution chart, Jinxin Fertility Group ranks #352 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 58%.
Is Jinxin Fertility Group's Days Payable too high?
Jinxin Fertility Group's current Days Payable of 49.95 is near median its 10-year median of 48.33. Over the past 10 years, this metric has ranged from a low of 40.76 to a high of 71.58. The Healthcare Providers & Services industry median Days Payable is 56.95. Jinxin Fertility Group's value of 49.95 is 12.3% below this industry median. Based on the distribution chart, Jinxin Fertility Group ranks #352 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Jinxin Fertility Group has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #352 out of 607 companies for Days Payable. This places Jinxin Fertility Group in the lower half of its industry. The industry median Days Payable is 56.95. Jinxin Fertility Group's value of 49.95 is 12.3% below this benchmark. Historically, Jinxin Fertility Group's own Days Payable has ranged from 40.76 to 71.58 over the past decade. While the company's 10-year median is 48.33 vs. the industry median of 56.95, Jinxin Fertility Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 56.95, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinxin Fertility Group's current Days Payable of 49.95 is 12.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jinxin Fertility Group and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 56.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current Days Payable is 49.95, which is near median its own 10-year median of 48.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Based on GuruFocus' analysis, Jinxin Fertility Group (HKSE:01951) is currently considered Possible Value Trap. The stock's GF Value™ is HK$3.74, compared to a current price of HK$2.16 — trading 42.2% below its estimated fair value. The current Days Payable is 49.95, which is near median its 10-year median of 48.33 and 12.3% below the Healthcare Providers & Services industry median of 56.95. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jinxin Fertility Group (HKSE:01951), the current Days Payable is 49.95 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (HKSE:01951) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of HK$2.16 is trading 42.2% below its estimated GF Value™ of HK$3.74.
GuruFocus considers Jinxin Fertility Group to be Possible Value Trap.
Key valuation signals for HKSE:01951:
Days Payable: 49.95 (near median its 10-year median of 48.33)
GF Value™: HK$3.74 vs. price of HK$2.16 (42.2% below fair value)
Industry Position: 12.3% below the Healthcare Providers & Services median (#352 of 607)
No single metric tells the full story. See the HKSE:01951 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for HKSE:01951
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01951 has been successfully added to your 
